FED'S BARKIN: LOOKING FOR MORE EVIDENCE OF INFLATION'S DECLINE

BARKIN: FED SHOULD ACT DELIBERATELY, KEEP CLOSE EYE ON ECONOMY

MNI BRIEF: China Equip't Renewal Policy Includes Foreign Firms

MNI China Daily Summary: Wednesday, July 17

MNI China Press Digest July 17:  Investment, LPR, H2 Priority

MNI: PBOC Net Injects CNY268 Bln Via OMO Wed; Rates Unchanged

Broad-based Softening In June Underlying Inflation Metrics

EZ/UK Bond Supply Calendar: Spain, France Auction on Thursday

EZ/UK T-Bill Calendar:1/3/6-Month UKTB Auction on Friday

RPT-MNI: Canada Sticks To Fiscal Anchors, Spends Chunk Of Windfall

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

Bayer (BAYN; Baa2 Neg, BBB S, BBB S)

HEALTHCARE

CDS moves wider, cash holds firm, no sign of Moodys.

  • Its been low vol for Pharma's recently including Bayer which after some strong deleveraging in FY23 has hit pause on its widening. We haven't seen the same for its CDS (Main member) that's now at +132, widening +16bps vs. cash 29's -6-8bp rally since earnings. Its moved basis to highest levels in recent months (~ +20bps).
  • We're not sure if protection is bid on nerves around Moody's (on neg outlook) who is taking its time to comment on earnings/FY24 guidance. As we've mentioned before, Bayer is priced for ~1-notch downgrade trading in-line with VTRS (Baa3 S, BBB- Neg) - VTRS does have positive outlook from equity analyst but still needs to delever this yr (which mgmt affirmed) to hold onto ratings.
  • Moves on Bayer CDS are not being driven by broader CDS/basis - Main is flat since earnings with BAYNGR spread +77bps to it & now the 3rd widest in the index.
Credit BulletsBulletHomepagemarkets-real-timeCredit
Credit BulletsBulletHomepagemarkets-real-timeCredit

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.